All Achievements
activity Overview of interim findings from a Survey on Patient Attitudes Toward Clinical Trial Processes In Chronic Liver Diseases
activity Glp1-agonist reduces alcohol intake and liver inflammation in a mouse model of alcohol-induced acute hepatitis.
activity Sex-based Disparities in Baseline Characteristics and Clinical Outcomes of patients with Decompensated Cirrhosis and Hepatic Hydrothorax
activity Prevalence of nonalcoholic fatty liver disease among adults with normal weight, overweight and obesity in the United States, 1999-2018.
activity A Case of Late-Onset Hepatic Sinusoidal Obstructive Syndrome/ Veno-occlusive Disease 1 Year Post Transplant.
activity Regional Variation in Baseline Characteristics and Clinical Outcomes of Decompensated Cirrhosis with Hepatic Hydrothorax
activity Alcohol and Liver Health
activity Hepatic hydrothorax portends worse inpatient outcomes in patients with decompensated cirrhosis
activity Pathways to GI Panel
activity Teens to Twenties Liver Wellness Guide
activity Metabolic features associated with nonalcoholic fatty liver disease among Asian-Americans, 2012-2018
activity Insulin resistance trends among lean patients with nonalcoholic fatty liver disease in the United States
activity Prognostic mitochondrial ribosomal protein MRPS30 expression in liver cancer: toward new biomarkers in metabolic liver disease
activity Pharmacotherapy for Weight loss in cirrhosis: A case series of GLP-1 agonist-associated weight loss
activity New Frontiers for Fatty Liver Disease: Updates on Clinical Trials and Drug Approval Status
activity STEM Professionals Speaker Series
activity Transient Elastography and FIB-4 Identify Portal Hypertension in Patients with Chronic Liver Disease
activity Haptoglobin 2 allele is associated with increased risk and severity of alcoholic hepatitis
activity Non-alcoholic fatty liver disease is associated with QTc lengthening in the general population
activity Enlarging Ectopic Thyroid in the Porta Hepatis